192 related articles for article (PubMed ID: 33979164)
1. Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1
Monastyrskyi A; Brockmeyer F; LaCrue AN; Zhao Y; Maher SP; Maignan JR; Padin-Irizarry V; Sakhno YI; Parvatkar PT; Asakawa AH; Huang L; Casandra D; Mashkouri S; Kyle DE; Manetsch R
J Med Chem; 2021 May; 64(10):6581-6595. PubMed ID: 33979164
[TBL] [Abstract][Full Text] [Related]
2. Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of Malaria.
Frueh L; Li Y; Mather MW; Li Q; Pou S; Nilsen A; Winter RW; Forquer IP; Pershing AM; Xie LH; Smilkstein MJ; Caridha D; Koop DR; Campbell RF; Sciotti RJ; Kreishman-Deitrick M; Kelly JX; Vesely B; Vaidya AB; Riscoe MK
ACS Infect Dis; 2017 Oct; 3(10):728-735. PubMed ID: 28927276
[TBL] [Abstract][Full Text] [Related]
3. ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria.
Miley GP; Pou S; Winter R; Nilsen A; Li Y; Kelly JX; Stickles AM; Mather MW; Forquer IP; Pershing AM; White K; Shackleford D; Saunders J; Chen G; Ting LM; Kim K; Zakharov LN; Donini C; Burrows JN; Vaidya AB; Charman SA; Riscoe MK
Antimicrob Agents Chemother; 2015 Sep; 59(9):5555-60. PubMed ID: 26124159
[TBL] [Abstract][Full Text] [Related]
4. Optimization of endochin-like quinolones for antimalarial activity.
Winter R; Kelly JX; Smilkstein MJ; Hinrichs D; Koop DR; Riscoe MK
Exp Parasitol; 2011 Feb; 127(2):545-51. PubMed ID: 21040724
[TBL] [Abstract][Full Text] [Related]
5. Prodrugs of bisthiazolium salts are orally potent antimalarials.
Vial HJ; Wein S; Farenc C; Kocken C; Nicolas O; Ancelin ML; Bressolle F; Thomas A; Calas M
Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15458-63. PubMed ID: 15492221
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity.
Domínguez JN; Charris JE; Lobo G; Gamboa de Domínguez N; Moreno MM; Riggione F; Sanchez E; Olson J; Rosenthal PJ
Eur J Med Chem; 2001 Jun; 36(6):555-60. PubMed ID: 11525846
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3.
Nicolas O; Margout D; Taudon N; Wein S; Calas M; Vial HJ; Bressolle FM
Antimicrob Agents Chemother; 2005 Sep; 49(9):3631-9. PubMed ID: 16127032
[TBL] [Abstract][Full Text] [Related]
8. Quinolone-3-diarylethers: a new class of antimalarial drug.
Nilsen A; LaCrue AN; White KL; Forquer IP; Cross RM; Marfurt J; Mather MW; Delves MJ; Shackleford DM; Saenz FE; Morrisey JM; Steuten J; Mutka T; Li Y; Wirjanata G; Ryan E; Duffy S; Kelly JX; Sebayang BF; Zeeman AM; Noviyanti R; Sinden RE; Kocken CHM; Price RN; Avery VM; Angulo-Barturen I; Jiménez-Díaz MB; Ferrer S; Herreros E; Sanz LM; Gamo FJ; Bathurst I; Burrows JN; Siegl P; Guy RK; Winter RW; Vaidya AB; Charman SA; Kyle DE; Manetsch R; Riscoe MK
Sci Transl Med; 2013 Mar; 5(177):177ra37. PubMed ID: 23515079
[TBL] [Abstract][Full Text] [Related]
9. Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activities.
Caldarelli SA; Hamel M; Duckert JF; Ouattara M; Calas M; Maynadier M; Wein S; Périgaud C; Pellet A; Vial HJ; Peyrottes S
J Med Chem; 2012 May; 55(10):4619-28. PubMed ID: 22591034
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bis-alkylamidoxime O-alkylsulfonates as orally available antimalarials.
Degardin M; Wein S; Gouni S; Tran Van Ba C; Duckert JF; Durand T; Escale R; Vial H; Vo-Hoang Y
ChemMedChem; 2012 Jun; 7(6):991-1001. PubMed ID: 22544438
[TBL] [Abstract][Full Text] [Related]
11. Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure-Activity and Structure-Property Relationship Studies.
Neelarapu R; Maignan JR; Lichorowic CL; Monastyrskyi A; Mutka TS; LaCrue AN; Blake LD; Casandra D; Mashkouri S; Burrows JN; Willis PA; Kyle DE; Manetsch R
J Med Chem; 2018 Feb; 61(4):1450-1473. PubMed ID: 29215279
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antimalarial activity, and structure-activity relationship of 7-(2-phenoxyethoxy)-4(1H)-quinolones.
Cross RM; Namelikonda NK; Mutka TS; Luong L; Kyle DE; Manetsch R
J Med Chem; 2011 Dec; 54(24):8321-7. PubMed ID: 22111907
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of Deuterated Endochin-Like Quinolones.
Pou S; Winter RW; Liebman KM; Dodean RA; Nilsen A; DeBarber A; Doggett JS; Riscoe MK
J Labelled Comp Radiopharm; 2024 May; 67(5):186-196. PubMed ID: 38661253
[TBL] [Abstract][Full Text] [Related]
14. Endochin optimization: structure-activity and structure-property relationship studies of 3-substituted 2-methyl-4(1H)-quinolones with antimalarial activity.
Cross RM; Monastyrskyi A; Mutka TS; Burrows JN; Kyle DE; Manetsch R
J Med Chem; 2010 Oct; 53(19):7076-94. PubMed ID: 20828199
[TBL] [Abstract][Full Text] [Related]
15. Progress in the Optimization of 4(1
Brockmeyer F; Manetsch R
Chimia (Aarau); 2017 Apr; 71(4):213-219. PubMed ID: 28446339
[TBL] [Abstract][Full Text] [Related]
16. Double prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
Courtens C; Risseeuw M; Caljon G; Maes L; Cos P; Martin A; Van Calenbergh S
Bioorg Med Chem Lett; 2019 May; 29(10):1232-1235. PubMed ID: 30879839
[TBL] [Abstract][Full Text] [Related]
17. Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).
Pidathala C; Amewu R; Pacorel B; Nixon GL; Gibbons P; Hong WD; Leung SC; Berry NG; Sharma R; Stocks PA; Srivastava A; Shone AE; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Hill A; Fisher NE; Warman AJ; Biagini GA; Ward SA; O'Neill PM
J Med Chem; 2012 Mar; 55(5):1831-43. PubMed ID: 22364416
[TBL] [Abstract][Full Text] [Related]
18. Improving solubility and oral bioavailability of a novel antimalarial prodrug: comparing spray-dried dispersions with self-emulsifying drug delivery systems.
Potharaju S; Mutyam SK; Liu M; Green C; Frueh L; Nilsen A; Pou S; Winter R; Riscoe MK; Shankar G
Pharm Dev Technol; 2020 Jun; 25(5):625-639. PubMed ID: 32031478
[TBL] [Abstract][Full Text] [Related]
19. Prodrugs of reverse fosmidomycin analogues.
Brücher K; Gräwert T; Konzuch S; Held J; Lienau C; Behrendt C; Illarionov B; Maes L; Bacher A; Wittlin S; Mordmüller B; Fischer M; Kurz T
J Med Chem; 2015 Feb; 58(4):2025-35. PubMed ID: 25633870
[TBL] [Abstract][Full Text] [Related]
20. Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
Reichenberg A; Wiesner J; Weidemeyer C; Dreiseidler E; Sanderbrand S; Altincicek B; Beck E; Schlitzer M; Jomaa H
Bioorg Med Chem Lett; 2001 Mar; 11(6):833-5. PubMed ID: 11277531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
